In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EHRA Ivory (& above) Members, Fellows of the ESC and Young combined Members

Complex atrial arrhythmias: are we closer to find the way to success?

Session Moderated ePosters 1: non-invasive rhythm diagnostics: bringing old and new together

Speaker Ines Aguiar Ricardo

Event : EHRA 2019

  • Topic : arrhythmias and device therapy
  • Sub-topic : Arrhythmias, General – Diagnostic Methods: Electrocardiography
  • Session type : Moderated Posters

Authors : I Aguiar Ricardo (Lisbon,PT), IS Goncalves (Lisbon,PT), IS Goncalves (Lisbon,PT), J Rigueira (Lisbon,PT), J Rigueira (Lisbon,PT), A Nunes-Ferreira (Lisbon,PT), A Nunes-Ferreira (Lisbon,PT), R Santos (Lisbon,PT), R Santos (Lisbon,PT), T Rodrigues (Lisbon,PT), T Rodrigues (Lisbon,PT), J Agostinho (Lisbon,PT), J Agostinho (Lisbon,PT), N Cunha (Lisbon,PT), N Cunha (Lisbon,PT), J Quaresma (Lisbon,PT), J Quaresma (Lisbon,PT), A Bernardes (Lisbon,PT), A Bernardes (Lisbon,PT), N Cortez-Dias (Lisbon,PT), N Cortez-Dias (Lisbon,PT), L Carpinteiro (Lisbon,PT), L Carpinteiro (Lisbon,PT), FJ Pinto (Lisbon,PT), FJ Pinto (Lisbon,PT), J Sousa (Lisbon,PT), J Sousa (Lisbon,PT)

I Aguiar Ricardo1 , IS Goncalves1 , IS Goncalves1 , J Rigueira1 , J Rigueira1 , A Nunes-Ferreira1 , A Nunes-Ferreira1 , R Santos1 , R Santos1 , T Rodrigues1 , T Rodrigues1 , J Agostinho1 , J Agostinho1 , N Cunha1 , N Cunha1 , J Quaresma1 , J Quaresma1 , A Bernardes1 , A Bernardes1 , N Cortez-Dias1 , N Cortez-Dias1 , L Carpinteiro1 , L Carpinteiro1 , FJ Pinto1 , FJ Pinto1 , J Sousa1 , J Sousa1 , 1Cardiology Department, Santa Maria Hospital, CHLN, CCUL, Lisbon University, Cardiology - Lisbon - Portugal ,


Introduction: Complex atrial arrhythmias (CAA) are usualy secondary to complex structural substrate modifications (heterogeneous myocardial fibrosis), making their mapping and ablation a true challenge. The emergence of high density mapping (allowing detailed substrate evaluation) and of innovative algorithms, not dependent on the definition of a window-of-interest (such as RippleMapTM and SparkleMapTM), has allowed us to investigate new mapping methodologies and avoid the use of potentially deleterious entrainment maneuvers during the procedure (arrhythmia instability).

Purpose: Evaluation of the success of a structured methodology of high density mapping of CAA, primarily based on the analysis of algorithms that are independent of a window-of-interest

Métodos: It was conducted an unicentric prospective study of consecutive patients with CAA submitted to electrophysiological study since June 2015. The mapping methodology was based on three principles: non-use of entrainment maneuvers; acquisition of the high density bipolar voltage map for detailed characterization of the substrate; interpretation of the arrhythmia mechanism by the analysis of the electrical propagation sequence represented by the RippleMapTM or SparkleMapTM (keeping activation map concealed).

Results: Thirty-five procedures were performed (63% men; mean age 66 years). Previous history of ablation was present in 54% of the patients (pulmonary vein isolation in 40%). The majority of the CAA studied (80%) had origin in the left atrium and 20% in the right atrium. The average of points collected per map was 2933, with a total mapping time of 37±19min and a map interpretation time of 28±16min. The arrhythmogenic mechanism was clearly identified in 97%: 71% macro-reentry, 20% focal origin, 5.7% micro-reentry; only 1 case was uninterpretable. In 86% of the cases, the CAA was terminated with first radiofrequency application and success was obtained in 83% (5 cases of failure due to inability to block the mitral isthmus and one case due to inability to block the roof line).

Conclusion: Our strategy of CAA mapping and ablation allowed the appropriate identification of the arrhythmia mechanism in 97% of the cases, leading to a more directed and circumscribed ablation strategy.

The free consultation period for this content is over.

It is now only available year-round to EHRA Ivory (& above) Members, Fellows of the ESC and Young combined Members

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are